Stock DANCAN DANCANN PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

All News Dancann Pharma A/S

Equities

DANCAN

DK0061410487

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
0.038 DKK -5.00% Intraday chart for Dancann Pharma A/S -5.00% +26.67%
18/06 DanCann Pharma A/S Provides Revenue Guidance for the Year 2024 CI
01/06 DanCann Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
DanCann Pharma: DanCann Pharma A/S announces outcome of the Rights Issue
PU
DanCann Pharma A/S announces outcome of the Rights Issue
AQ
DanCann Pharma: DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank
PU
DanCann Pharma: DanCann Pharma A/S: Solid growth in the Rx portfolio
PU
DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank
AQ
DanCann Pharma A/S: Solid growth in the Rx portfolio
AQ
DanCann Pharma A/S Provides Revenue Guidance for the Year 2024
CI
DanCann Pharma: DanCann Pharma A/S: Germany trends – prescriptions for medicinal cannabis positively influenced by new legalization
PU
DanCann Pharma A/S: Germany trends - prescriptions for medicinal cannabis positively influenced by new legalization
AQ
DanCann Pharma: DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio
PU
DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio
AQ
DanCann Pharma A/S: The subscription period of DanCann Pharma's Rights Issue begins today
AQ
DanCann Pharma A/S: Publishes Q1-2024 Report
AQ
DanCann Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING
AQ
DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum
AQ
DanCann Pharma A/S: Capital reduction completed
AQ
NOTICE OF ANNUAL GENERAL MEETING 2024 IN DANCANN PHARMA A/S
AQ
DanCann Pharma A/S Publishes Its Annual Report for 2023: A Year of Strategic Review and Future Focus on Capital Efficiency and Profitability
AQ
DanCann Pharma A/S: Updated time plan and material terms of the rights issue
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DANCAN Stock
  4. News Dancann Pharma A/S